0000899243-19-027028.txt : 20191108 0000899243-19-027028.hdr.sgml : 20191108 20191108191236 ACCESSION NUMBER: 0000899243-19-027028 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191108 FILED AS OF DATE: 20191108 DATE AS OF CHANGE: 20191108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hayden Michael R CENTRAL INDEX KEY: 0001352908 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 191205336 MAIL ADDRESS: STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION STREET 2: 1203-4464 MARKHAM STREET CITY: VICTORIA STATE: A1 ZIP: V8Z 7X8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 4155004614 MAIL ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2019-11-08 0 0001785173 89bio, Inc. ETNB 0001352908 Hayden Michael R C/O 89BIO, INC. 535 MISSION STREET, 14TH FLOOR SAN FRANCISCO CA 94105 1 0 0 0 Series A Preferred Stock Common Stock 58978 I See footnote Stock Option (Right to Buy) 1.93 2028-11-09 Common Stock 88467 D Stock Option (Right to Buy) 1.93 2029-01-30 Common Stock 9380 D Stock Option (Right to Buy) 3.11 2029-07-30 Common Stock 36367 D Each share of Series A Preferred Stock is convertible into common stock on a one-for-6.217 basis into the number of shares of common stock shown in column 3 at any time at the holder's election and automatically immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock has no expiration date. These shares are held directly by Genworks 2 Consulting Inc., over which the Reporting Person's wife has sole voting and investment power. This option represents a right to purchase a total of 86,467 shares of the Issuer's common stock, one quarter of which vested on April 16, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years. This option represents a right to purchase a total of 9,390 shares of the Issuer's common stock, one quarter of which vested on April 16, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years. This option represents a right to purchase a total of 36,367 shares of the Issuer's common stock, one quarter of which will vest on July 23, 2020, with the remaining three quarters vesting in equal quarterly installments over the following three years. Exhibit 24 - Power of Attorney /s/ Ryan A. Murr, Attorney-in-Fact for Michael R. Hayden 2019-11-08 EX-24 2 attachment1.htm EX-24 DOCUMENT

                               POWER OF ATTORNEY

          Know all by these presents that the undersigned hereby constitutes and
appoints each of Rohan A. Palekar, Ryan Martins and Ryan A. Murr, and any of
their substitutes, signing singly, as the undersigned's true and lawful
attorney-in-fact to:

1.      prepare, execute in the undersigned's name and on the undersigned's
        behalf, and submit to the U.S. Securities and Exchange Commission (the
        "SEC") a Form ID, including amendments thereto, and any other documents
        necessary or appropriate to obtain codes, passwords, and passphrases
        enabling the undersigned to make electronic filings with the SEC of
        reports required by the Securities Exchange Act of 1934 or any rule or
        regulation of the SEC;

2.      execute for and on behalf of the undersigned, in the undersigned's
        capacity as a director of 89bio, Inc. (the "Company"), Forms 3, 4, and
        5 in accordance with Section 16(a) of the Securities Exchange Act of
        1934 and the rules thereunder;

3.      do and perform any and all acts for and on behalf of the undersigned
        which may be necessary or desirable to complete and execute any such
        Form 3, 4, or 5, complete and execute any amendment or amendments
        thereto, and timely file such form with the SEC and any securities
        exchange or similar authority; and

4.      take any other action of any type whatsoever in connection with the
        foregoing which, in the opinion of such attorney-in-fact, may be of
        benefit to, in the best interest of, or legally required by, the
        undersigned, it being understood that the documents executed by such
        attorney-in-fact on behalf of the undersigned pursuant to this Power of
        Attorney shall be in such form and shall contain such terms and
        conditions as such attorney-in-fact may approve in such attorney-in-
        fact's discretion.

          The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that each such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted.  The undersigned also ratifies hereby any
action previously taken by each attorney-in-fact that would have been authorized
by this power of attorney if it has been in effect at the time such action was
taken.  The undersigned acknowledges that each attorney-in-fact, in serving in
such capacity at the request of the undersigned, is not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934, as amended.

          This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to each
of the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 31st day of October, 2019.

                                        /s/ Michael R. Hayden
                                       ----------------------------------------
                                        Michael R. Hayden